Surgical menopause as a risk factor for the early development of comorbid conditions in reproductive-aged women
- Authors: Shabalova O.V.1, Yureneva S.V.1, Ermakova E.I.1, Khokhlova S.V.1, Gardanova Z.R.1,2, Yakushevskaya O.V.1
-
Affiliations:
- Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
- Issue: No 6 (2021)
- Pages: 54-59
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/249130
- DOI: https://doi.org/10.18565/aig.2021-6.54-59
- ID: 249130
Cite item
Abstract
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
Olga V. Shabalova
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: olga.shabalova93@gmail.com
graduate student, Department of Gynecological Endocrinology
Svetlana V. Yureneva
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: syureneva@gmail.com
Dr. Med. Sci., Leading Researcher, Department of Gynecological Endocrinology
Elena I. Ermakova
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: ermakova.health@mail.ru
PhD, Senior Researcher, Department of Gynecological Endocrinology
Svetlana V. Khokhlova
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: s_hohlova@oparina4.ru
Dr. Med. Sci., Head of Oncology Department of Antitumor Drug Therapy
Zhanna R. Gardanova
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Email: zanna7777@inbox.ru
Dr. Med. Sci., Professor
Oksana V. Yakushevskaya
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: aluckyone777@gmail.com
PhD, Researcher
References
- Указ Президента Российской Федерации от 07.05. 2018 № 204 (ред. от 19.07.2018) «О национальных целях и стратегических задачах развития Российской Федерации на период до 2024 года». Справочно-правовая система «Консультант Плюс». [Decree of the President of the Russian Federation of 07.05. 2018 No. 204 (ed. From 19.07.2018) "On national goals and strategic objectives of the development of the Russian Federation for the period until 2024." Legal reference system "Consultant Plus". (in Russian)].
- Каприн А.Д., Старинский В.В., Шахзадова А.О., ред. Злокачественные новообразования в россии в 2019 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России; 2020. 252с. [Kaprin A.D., Starinsky V.V., Shahzadova A.O., ed. Malignant neoplasms in Russia in 2019 (morbidity and mortality). M., 2020; 252 p. (in Russian)].
- Vermeulen R.F.M., Korse C.M., Kenter G.G., Brood-van Zanten M.M.A., van Beurden M. Safety of hormone replacement therapy following risk-reducing salpingo-oophorectomy: systematic review of literature and guidelines. Climacteric. 2019; 22(4): 352-60. https://dx.doi.org/10.1080/13697137.2019.1582622.
- Marchetti C., De Felice F, Boccia S., Sassu C., Di Donato V., Perniola G. et al. Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysis. Crit. Rev. Oncol. Hematol. 2018; 132: 111-5. https://dx.doi.org/10.1016/j.critrevonc.2018.09.018.
- Delamater L., Santoro N. Management of the perimenopause. Clin. Obstet. Gynecol. 2018; 61(3): 419-32. https://dx.doi.org/10.1097/ GRF.0000000000000389.
- Dehghan A., Vasan S.K., Fielding B.A., Karpe F. A prospective study of the relationships between change in body composition and cardiovascular risk factors across the menopause. Menopause. 2021; 28(4): 400-6. https://dx.doi.org/10.1097/GME.0000000000001721.
- Schorr M., Dichtel L.E., Gerweck A.V., Valer aR.D., Torriani M., Miller K.K. et al. Sex differences in body composition and association with cardiometabolic risk. Biol. Sex Differ. 2018; 9(1): 28. https://dx.doi.org/10.1186/s13293-018-0189-3.
- Sipila S., Tormakangas T., Sillanpaa E., Aukee P., Kujala U.M., Kovanen V. et al. Muscle and bone mass in middle-aged women: role of menopausal status and physical activity. J. Cachexia Sarcopenia Muscle. 2020; 11(3): 698-709. https://dx.doi.org/10.1002/jcsm.12547.
- Razmjou S., Abdulnour J., Bastard J.-P., Fellahi S., Doucet Ё., Brochu M. et al. Body composition, cardiometabolic risk factors, physical activity, and inflammatory markers in premenopausal women after a 10-year follow-up: a MONET study. Menopause. 2018; 25(1): 89-97. https://dx.doi.org/10.1097/ GME.0000000000000951.
- Geisler C., Braun W, Pourhassan M., Schweitzer L., Gluer C.-C., Bosy-Westphal A. et al. Gender-Specific Associations in age-related changes in resting energy Expenditure (REE) and MRI Measured Body Composition in Healthy caucasians. J. Gerontol. A. Biol. Sci. Med. Sci. 2016; 71(7): 941-6. https://dx.doi.org/10.1093/gerona/glv211.
- Yazdkhasti M., Tourzani ZM., Roozbeh N., Hasanpour V., Saeieh S.E., Abdi F. The association between diabetes and age at the onset of menopause: a systematic review protocol. Syst. Rev. 2019; 8(1): 80. https://dx.doi.org/10.1186/s13643-019-0989-5.
- Chiang C.H., Chen W., Tsai I.J., Hsu C.Y., Wang J.H., Lin S.Z. et al. Diabetes mellitus risk after hysterectomy. Medicine (Baltimore). 2021; 100(4): e24468. https:dx.doi.org/10.1097/MD.0000000000024468.
- Pandeya N., Huxley R.R., Chung H.-F., Dobson A.J., Kuh D., Hardy R. et al. Female reproductive history and risk of type 2 diabetes: A prospective analysis of 126 721 women. Diabetes Obes. Metab. 2018; 20(9): 2103-12. https:dx.doi.org/10.1111/dom.13336.
- Юренева С.В., Ермакова Е.И. Оценка эффективности альтернативных методов лечения менопаузальных симптомов у женщин в постменопаузе. Медицинский совет. 2017; 19(1): 76-80. [Yureneva S.V., Ermakova E.I. Evaluating the effectiveness of alternative treatments for menopausal symptoms in postmenopausal women. Medical Council. 2017; 19(1): 76-80. (in Russian)]. https://dx.doi.org/10.21518/2079-701X-2017-2-76-80.
- Zhu D., Chung H.-F., Dobson A.J., Pandeya N., Brunner E.J., Kuh D. et al. Type of menopause, age of menopause and variations in the risk of incident cardiovascular disease: pooled analysis of individual data from 10 international studies. Hum. Reprod. 2020; 35(8): 1933-43. https://dx.doi.org/10.1093/humrep/deaa124.
- Dam V., van der Schouw Y.T., Onland-Moret N.C., Groenwold R.H.H., Peters S.A.E., Burgess S. et al. Association of menopausal characteristics and risk of coronary heart disease: a pan-European case-cohort analysis. Int. J. Epidemiol. 2019; 48(4): 1275-85. https://dx.doi.org/10.1093/ije/dyz016.
- Anagnostis P., Bitzer J., Cano A., Ceausu I., Chedraui P., Durmusoglu F. et al. Menopause symptom management in women with dyslipidemias: An EMAS clinical guide. Maturitas. 2020; 135: 82-8. https://dx.doi.org/10.1016/j.maturitas.2020.03.007.
- Fredslund S.O., Gravholt C.H., Laursen B.E., Jensen A.B. Key metabolic parameters change significantly in early breast cancer survivors: an explorative PILOT study J. Transl. Med. 2019; 17(1): 105. https://dx.doi.org/10.1186/s12967-019-1850-2.
- Якушевская О.В., Юренева С.В., Протасова А.Е., Шабалова О.В. Альтернативная и комплементарная терапия менопаузальных расстройств после радикального лечения рака молочной железы. Акушерство и гинекология. 2021; 5: 72-8. https://dx.doi.org/10.18565/aig.202L5.72-78.
- Bicakli D.H., Varol U., Degirmenci M., Tunali D., Cakar B., Durusoy R. et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J. Oncol. Pharm. Pract. 2016; 22(1): 46-53. https://dx.doi.org/10.1177/1078155214551315.
- Zhang L., Ruan X., Cui Y., Gu M., Mueck A.O. Menopausal symptoms and associated social and environmental factors in midlife chinese women. Clin. Interv. Aging. 2020; 15: 2195-208. https://dx.doi.org/10.2147/CIA.S278976.
- Bansal R., Aggarwal N. Menopausal hot flashes: A concise review. J. Midlife Health. 2019; 10(1): 6-13. https://dx.doi.org/10.4103/jmh.JMH_7_19.
- Thurston R.C., Aslanidou Vlachos H.E., Derby C.A., Jackson E.A., Brooks M.M., Matthews K.A. et al. Menopausal vasomotor symptoms and risk of incident cardiovascular disease events in SWAN. J. Am. Heart Assoc. 2021; 10(3): e017416. https://dx.doi.org/10.1161/JAHA.120.017416.
- Jaeger M. de B., Mina C.S., Alves S., Schuh G.J., Wender M.C., Manfro G.G. Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause. Rev. Bras. Psiquiatr. 2020; 43: 277-84. https://dx.doi.org/10.1590/1516-4446-2020-0871.
- Pinkerton J.V., Santen R.J. Managing vasomotor symptoms in women after cancer. Climacteric. 2019; 22(6): 544-52. https://dx.doi.org/10.1080/13697137.2019.1600501.
- Choi Y., Chang Y., Kim B.K., Kang D., Kwon M.J., Kim C.W. et al. Menopausal stages and serum lipid and lipoprotein abnormalities in middle-aged women. Maturitas. 2015; 80(4): 399-405. https://dx.doi.org/10.1016/j.maturitas.2014.12.016.
- Gray K.E., Katon J.G., LeBlanc E.S., Woods N.F., Bastian L.A., Reiber G.E. et al. Vasomotor symptom characteristics: are they risk factors for incident diabetes? Menopause. 2018; 25(5): 520-30. https://dx.doi.org/10.1097/ GME.0000000000001033.
- Muka T., Oliver-Williams C., Colpani V., Kunutsor S., Chowdhury S., Chowdhury R. et al. Association of vasomotor and other menopausal symptoms with risk of cardiovascular disease: A systematic review and meta-analysis. PLoS One. 2016; 11(6): e0157417. https://dx.doi.org/10.1371/journal.pone.0157417.
- Kravitz H.M., Janssen I., Bromberger J.T., Matthews K.A., Hall M.H., Ruppert K. et al. Sleep trajectories before and after the final menstrual period in the Study of Women’s Health Across the Nation (SWAN). Curr. Sleep Med. Reports. 2017; 3(3): 235-50. https://dx.doi.org/10.1007/s40675-017-0084-1.
- Maki P.M., Kornstein S.G., Joffe H., Bromberger J.T., Freeman E.W., Athappilly G. et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause. 2018; 25(10): 1069-85. https://dx.doi.org/10.1097/GME.0000000000001174.
- Marino J.L., Saunders C.M., Emery L.I., Green H., Doherty D.A., Hickey M. How does adjuvant chemotherapy affect menopausal symptoms, sexual function, and quality of life after breast cancer? Menopause. 2016; 23(9): 1000-8. https:// dx.doi.org/10.1097/GME.0000000000000664.
- Forbes J.F., Sestak I., Howell A., Bonanni B., Bundred N., Levy C. et al. Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): A double-blind, randomised controlled trial. Lancet. 2016; 387(10021): 866-73. https://dx.doi.org/10.1016/S0140-6736(15)01129-0.
- Freeman E.W., Sammel M.D., Gross S.A., Pien G.W. Poor sleep in relation to natural menopause: a population-based 14-year follow-up of midlife women. Menopause. 2015; 22(7): 719-26. https://dx.doi.org/10.1097/ GME.0000000000000392.
- Wilson L., Pandeya N., Byles J., Mishra G. Hysterectomy and incidence of depressive symptoms in midlife women: the Australian Longitudinal Study on Women’s Health. Epidemiol. Psychiatr. Sci. 2018; 27(4): 381-92. https://dx.doi.org/10.1017/S2045796016001220.
- Jones J.M., Fitch M., Bongard J., Maganti M., Gupta A., D’Agostino N. et al. The needs and experiences of post-treatment adolescent and young adult cancer survivors. J. Clin. Med. 2020; 9(5): 1444. https://dx.doi.org/10.3390/jcm9051444.
- Беляев А.М., Чулкова В.А., Семиглазова Т.Ю., Рогачев М.В., ред. Онкопсихология для врачей-онкологов и медицинских психологов. Руководство. 2-е изд. Санкт-Петербург; 2018. [Belyaev A.M., Chulkova V.A., Semiglazova T.Yu., Rogachev M.V., ed. Oncopscycology for oncologists and medical psychologists. Guide. 2nd edition. St. Petersburg; 2018. (in Russian)].
- Miller V.M., Jayachandran M., Barnes J.N., Mielke M.M., Kantarci K., Rocca W.A. Risk factors of neurovascular ageing in women. J. Neuroendocr. 2020; 32(1): e12777. https://dx.doi.org/10.1111/jne.12777.
- Koebele S.V., Mennenga S.E., Hiroi R., Quihuis A.M., Hewitt L.T., Poisson M.L. et al. Cognitive changes across the menopause transition: A longitudinal evaluation of the impact of age and ovarian status on spatial memory. Horm. Behav. 2017; 87: 96-114. https://dx.doi.org/10.1016/j.yhbeh.2016.10.010.
- Novick A.M., Scott A.T., Neill Epperson C., Schneck C.D. Neuropsychiatric effects of tamoxifen: Challenges and opportunities. Front. Neuroendocrinol. 2020; 59: 100869. https://dx.doi.org/10.1016/j.yfrne.2020.100869.
- Yang Y., Hendrix C.C. Cancer-related cognitive impairment in breast cancer patients: influences of psychological variables. Asia-Pac. J. Oncol. Nurs. 2018; 5(3): 296-306. https://dx.doi.org/10.4103/apjon.apjon_16_18.
Supplementary files
![](/img/style/loading.gif)